Jay Barth

3.8k total citations
69 papers, 1.3k citations indexed

About

Jay Barth is a scholar working on Physiology, Surgery and Molecular Biology. According to data from OpenAlex, Jay Barth has authored 69 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Physiology, 17 papers in Surgery and 15 papers in Molecular Biology. Recurrent topics in Jay Barth's work include Lysosomal Storage Disorders Research (21 papers), Helicobacter pylori-related gastroenterology studies (14 papers) and Gastroesophageal reflux and treatments (12 papers). Jay Barth is often cited by papers focused on Lysosomal Storage Disorders Research (21 papers), Helicobacter pylori-related gastroenterology studies (14 papers) and Gastroesophageal reflux and treatments (12 papers). Jay Barth collaborates with scholars based in United States, United Kingdom and Australia. Jay Barth's co-authors include A. Reha, Gary Elfring, Nimish Vakil, François Lanza, Howard Schwartz, Stuart W. Peltz, Erik Henricson, Craig M. McDonald, Richard T. Abresch and Carlos Perdomo and has published in prestigious journals such as Circulation, Gastroenterology and PLoS ONE.

In The Last Decade

Jay Barth

63 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay Barth United States 18 478 416 329 218 217 69 1.3k
T Maekawa Japan 20 306 0.6× 379 0.9× 63 0.2× 126 0.6× 129 0.6× 87 1.2k
Patricia Grabowski Germany 28 717 1.5× 276 0.7× 81 0.2× 562 2.6× 36 0.2× 75 2.2k
Simona Fecarotta Italy 17 207 0.4× 125 0.3× 299 0.9× 165 0.8× 74 0.3× 41 775
Kristine Juul Hare Denmark 20 443 0.9× 588 1.4× 167 0.5× 106 0.5× 107 0.5× 40 1.4k
Enza Mozzillo Italy 21 313 0.7× 413 1.0× 127 0.4× 115 0.5× 125 0.6× 91 1.6k
J D Teale United Kingdom 26 492 1.0× 181 0.4× 116 0.4× 342 1.6× 38 0.2× 51 1.6k
Toru Tanaka Japan 20 323 0.7× 149 0.4× 157 0.5× 184 0.8× 28 0.1× 68 1.2k
James R. Gray United States 20 216 0.5× 465 1.1× 144 0.4× 115 0.5× 266 1.2× 44 1.4k
Jose G. Molina United States 23 475 1.0× 162 0.4× 176 0.5× 98 0.4× 23 0.1× 30 1.8k
Tsukasa Saito Japan 20 468 1.0× 165 0.4× 192 0.6× 267 1.2× 34 0.2× 76 1.8k

Countries citing papers authored by Jay Barth

Since Specialization
Citations

This map shows the geographic impact of Jay Barth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Barth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Barth more than expected).

Fields of papers citing papers by Jay Barth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Barth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Barth. The network helps show where Jay Barth may publish in the future.

Co-authorship network of co-authors of Jay Barth

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Barth. A scholar is included among the top collaborators of Jay Barth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Barth. Jay Barth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shields, Alan L., Roger E. Lamoureux, Fiona Taylor, et al.. (2021). FABry Disease Patient-Reported Outcome-GastroIntestinal (FABPRO-GI): A new Fabry disease-specific gastrointestinal outcomes instrument. Quality of Life Research. 30(10). 2983–2994. 14 indexed citations
2.
Reyes, Emily de los, Kathrin Meyer, Lenora Lehwald, et al.. (2020). Single-dose AAV9-CLN6 gene transfer stabilizes motor and language function in CLN6-type Batten disease: Interim results from the first clinical gene therapy trial. Molecular Genetics and Metabolism. 129(2). S46–S47. 3 indexed citations
3.
Kain, Renate, Zoltán Prohászka, Alice Schmidt, et al.. (2019). Pregnancy Outcome after Exposure to Migalastat for Fabry Disease: A Clinical Report. Case Reports in Obstetrics and Gynecology. 2019(3). 1–7. 2 indexed citations
4.
5.
Corroënne, R., Jay Barth, William E. Whitehead, et al.. (2019). Chorioamniotic membrane separation following fetal myelomeningocele repair: incidence, risk factors and impact on perinatal outcome. Ultrasound in Obstetrics and Gynecology. 56(5). 684–693. 19 indexed citations
6.
Narita, Ichiei, Toya Ohashi, Norio Sakai, et al.. (2019). Efficacy and safety of migalastat in a Japanese population: a subgroup analysis of the ATTRACT study. Clinical and Experimental Nephrology. 24(2). 157–166. 10 indexed citations
7.
Schiffmann, Raphael, Daniel G. Bichet, Ana Jovanović, et al.. (2018). Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trial. Orphanet Journal of Rare Diseases. 13(1). 68–68. 25 indexed citations
8.
Schiffmann, Raphael, Elfrida R. Benjamin, Jeffrey P. Castelli, et al.. (2017). Low frequency of Fabry disease in patients with common heart disease. Genetics in Medicine. 20(7). 754–759. 8 indexed citations
9.
Paller, Amy S., Roberta De Nardi, Hung Do, et al.. (2017). 701 Investigation of the absorption of allantoin in vitro skin models to support wound healing. Journal of Investigative Dermatology. 137(5). S120–S120. 1 indexed citations
10.
Finkel, Richard S., Kevin M. Flanigan, Brenda Wong, et al.. (2013). Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy. PLoS ONE. 8(12). e81302–e81302. 172 indexed citations
11.
Henricson, Erik, Richard T. Abresch, Jay J. Han, et al.. (2012). Percent-Predicted 6-Minute Walk Distance in Duchenne Muscular Dystrophy to Account for Maturational Influences. PLoS Currents. 4. RRN1297–RRN1297. 57 indexed citations
12.
Kerem, Eitan, M. Wilschanski, K. De Boeck, et al.. (2011). 65 Phase 3 study of ataluren (PTC124®) in nonsense mutation cystic fibrosis (nmCF): baseline data. Journal of Cystic Fibrosis. 10. S17–S17. 6 indexed citations
13.
14.
Vakil, Nimish, François Lanza, Howard Schwartz, & Jay Barth. (2004). Seven‐day therapy for Helicobacter pylori in the United States. Alimentary Pharmacology & Therapeutics. 20(1). 99–107. 140 indexed citations
15.
Ohning, Gordon, John H. Walsh, Joseph R. Pisegna, et al.. (2003). Rabeprazole is superior to omeprazole for the inhibition of peptone meal‐stimulated gastric acid secretion in Helicobacter pylori‐negative subjects. Alimentary Pharmacology & Therapeutics. 17(9). 1109–1114. 17 indexed citations
16.
Gardner, Jerry D., et al.. (2002). Integrated acidity and rabeprazole pharmacology. Alimentary Pharmacology & Therapeutics. 16(3). 455–464. 33 indexed citations
17.
Moskovitz, Moti, et al.. (2000). Rabeprazole for the prevention of pathologic and symptomatic relapse of erosive or ulcerative gastroesophageal reflux disease. The American Journal of Gastroenterology. 95(11). 3081–3088. 28 indexed citations
18.
Johnson, David S., et al.. (2000). The benefit/risk profile of rabeprazole, a new proton-pump inhibitor. European Journal of Gastroenterology & Hepatology. 12(7). 799–806. 5 indexed citations
19.
Barth, Jay, Richard J. Deckelbaum, Thomas J. Starc, et al.. (1999). Family history of early cardiovascular disease in children with moderate to severe hypercholesterolemia: Relationship to lipoprotein (a) and low-density lipoprotein cholesterol levels. Journal of Laboratory and Clinical Medicine. 133(3). 237–244. 12 indexed citations
20.
Shank, Brenda, D. David Dershaw, James F. Caravelli, Jay Barth, & Warren E. Enker. (1990). A prospective study of the accuracy of preoperative computed tomographic staging of patients with biopsy-proven rectal carcinoma. Diseases of the Colon & Rectum. 33(4). 285–290. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T Maekawa Breakdown of academic impact, for papers by Patricia Grabowski Breakdown of academic impact, for papers by Simona Fecarotta Breakdown of academic impact, for papers by Kristine Juul Hare Breakdown of academic impact, for papers by Enza Mozzillo Breakdown of academic impact, for papers by J D Teale Breakdown of academic impact, for papers by Toru Tanaka Breakdown of academic impact, for papers by James R. Gray Breakdown of academic impact, for papers by Jose G. Molina Breakdown of academic impact, for papers by Tsukasa Saito
Rankless by CCL
2026